Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Cash from Investing Activities (2016 - 2026)

Standard Biotools has reported Cash from Investing Activities over the past 16 years, most recently at -$8.0 million for Q4 2025.

  • Quarterly Cash from Investing Activities fell 131.25% to -$8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.4 million through Dec 2025, down 92.45% year-over-year, with the annual reading at $27.4 million for FY2025, 92.45% down from the prior year.
  • Cash from Investing Activities was -$8.0 million for Q4 2025 at Standard Biotools, down from -$6.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $318.1 million in Q1 2024 and troughed at -$138.2 million in Q2 2022.
  • The 5-year median for Cash from Investing Activities is -$868000.0 (2022), against an average of $15.7 million.
  • Year-over-year, Cash from Investing Activities tumbled 1419.96% in 2022 and then surged 5071.66% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$10.8 million in 2021, then soared by 472.6% to $40.2 million in 2022, then tumbled by 132.59% to -$13.1 million in 2023, then soared by 296.13% to $25.7 million in 2024, then plummeted by 131.25% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Cash from Investing Activities are -$8.0 million (Q4 2025), -$6.7 million (Q3 2025), and $27.5 million (Q2 2025).